Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
Patsner
Bruce
B
Health Law & Policy Institute, University of Houston Law Center, Houston, TX, USA.
D000329:Advertising; D001688:Biological Products / Q000627:therapeutic use; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D017277:Drug Approval; D004339:Drug Compounding / Q000266:history; D004345:Drug Industry; D011307:Drug Prescriptions; D049673:History, 20th Century; D020249:Hormone Replacement Therapy; D006801:Humans; D020407:Internet; D007880:Legislation, Drug; D008593:Menopause / Q000187:drug effects; D009938:Organizations; D010593:Pharmaceutical Services / Q000331:legislation & jurisprudence*; D009626:Terminology as Topic; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products